Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dyadic International Inc

DYAI
Current price
1.15 USD -0.029 USD (-2.47%)
Last closed 1.13 USD
ISIN US26745T1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 29 477 600 USD
Yield for 12 month -40.06 %
1Y
3Y
5Y
10Y
15Y
DYAI
21.11.2021 - 28.11.2021

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. Address: 1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6 USD

P/E ratio

Dividend Yield

Current Year

+2 898 806 USD

Last Year

+2 930 303 USD

Current Quarter

+385 896 USD

Last Quarter

+334 617 USD

Current Year

+922 957 USD

Last Year

+807 110 USD

Current Quarter

+83 940 USD

Last Quarter

+190 662 USD

Key Figures DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -528.5 %
PE Ratio
Return On Assets TTM -46.28 %
PEG Ratio
Return On Equity TTM -127.38 %
Wall Street Target Price 6 USD
Revenue TTM 1 804 108 USD
Book Value 0.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -53.9 %
Dividend Yield
Gross Profit TTM 807 110 USD
Earnings per share -0.27 USD
Diluted Eps TTM -0.27 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DYAI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.8228
Enterprise Value Revenue 13.8265
Price Sales TTM 16.3392
Enterprise Value EBITDA -2.9344
Price Book MRQ 9.3043

Financials DYAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DYAI

For 52 weeks

0.93 USD 2.67 USD
50 Day MA 1.28 USD
Shares Short Prior Month 142 377
200 Day MA 1.51 USD
Short Ratio 4.1
Shares Short 121 995
Short Percent 0.61 %